Yuko Y. Palesch - Publications

Affiliations: 
Medical University of South Carolina, Charleston, SC, United States 
Area:
Biostatistics Biology

119 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Farrant M, Easton JD, Adelman EE, Cucchiara BL, Barsan WG, Tillman HJ, Elm JJ, Kim AS, Lindblad AS, Palesch YY, Zhao W, Pauls K, Walsh KB, Martí-Fàbregas J, Bernstein RA, et al. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis. Jama Network Open. 2: e1910769. PMID 31490536 DOI: 10.1001/jamanetworkopen.2019.10769  0.4
2016 Qureshi AI, Palesch YY, Barsan WG, Hanley DF, Hsu CY, Martin RL, Moy CS, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Wang Y, Yamamoto H, Yoon BW. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. The New England Journal of Medicine. PMID 27276234 DOI: 10.1056/NEJMoa1603460  0.36
2016 Lemmens R, Hamilton SA, Liebeskind DS, Tomsick TA, Demchuk AM, Nogueira RG, Marks MP, Jahan R, Gralla J, Yoo AJ, Yeatts SD, Palesch YY, Saver JL, Pereira VM, Broderick JP, et al. Effect of endovascular reperfusion in relation to site of arterial occlusion. Neurology. PMID 26802090 DOI: 10.1212/WNL.0000000000002399  0.36
2015 Broderick JP, Palesch YY, Janis LS. The National Institutes of Health StrokeNet: A User's Guide. Stroke; a Journal of Cerebral Circulation. PMID 26715457 DOI: 10.1161/STROKEAHA.115.011743  0.36
2015 Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC, Khalessi AA, Levy EI, Palesch YY, Prabhakaran S, Saposnik G, Saver JL, Smith EE. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke; a Journal of Cerebral Circulation. PMID 26696642 DOI: 10.1161/STR.0000000000000086  0.36
2015 Broderick JP, Berkhemer OA, Palesch YY, Dippel DW, Foster LD, Roos YB, van der Lugt A, Tomsick TA, Majoie CB, van Zwam WH, Demchuk AM, van Oostenbrugge RJ, Khatri P, Lingsma HF, Hill MD, et al. Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data. Stroke; a Journal of Cerebral Circulation. PMID 26486865 DOI: 10.1161/STROKEAHA.115.011397  0.36
2015 Hill MD, Martin RH, Palesch YY, Moy CS, Tamariz D, Ryckborst KJ, Jones EB, Weisman D, Pettigrew C, Ginsberg MD. Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial. Plos One. 10: e0131390. PMID 26325387 DOI: 10.1371/journal.pone.0131390  0.36
2015 Tomsick TA, Foster LD, Liebeskind DS, Hill MD, Carrozella J, Goyal M, von Kummer R, Demchuk AM, Dzialowski I, Puetz V, Jovin T, Morales H, Palesch YY, Broderick J, Khatri P, et al. Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial. Ajnr. American Journal of Neuroradiology. 36: 2074-81. PMID 26228892 DOI: 10.3174/ajnr.A4421  0.36
2015 Liebeskind DS, Albers GW, Crawford K, Derdeyn CP, George MS, Palesch YY, Toga AW, Warach S, Zhao W, Brott TG, Sacco RL, Khatri P, Saver JL, Cramer SC, Wolf SL, et al. Imaging in StrokeNet: Realizing the Potential of Big Data. Stroke; a Journal of Cerebral Circulation. 46: 2000-6. PMID 26045600 DOI: 10.1161/STROKEAHA.115.009479  0.36
2015 Weng Y, Palesch YY, DeSantis SM, Zhao W. Assessing the Impact of Safety Monitoring on the Efficacy Analysis in Large Phase III Group Sequential Trials with Non-Trivial Safety Event Rate. Journal of Biopharmaceutical Statistics. PMID 26010228 DOI: 10.1080/10543406.2015.1052473  0.36
2015 Palesch YY, Yeatts SD, Tomsick TA, Foster LD, Demchuk AM, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, von Kummer R, Molina CA, Goyal M, Schonewille WJ, Mazighi M, et al. Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial. Stroke; a Journal of Cerebral Circulation. 46: 1321-7. PMID 25858239 DOI: 10.1161/STROKEAHA.115.009180  0.36
2015 Georgiadis AL, Palesch YY, Zygun D, Hemphill JC, Robertson CS, Leroux PD, Suarez JI. Multi-modality neuro-monitoring: conventional clinical trial design. Neurocritical Care. 22: 369-77. PMID 25832350 DOI: 10.1007/s12028-015-0134-9  0.36
2015 Nowacki AS, Zhao W, Palesch YY. A surrogate-primary replacement algorithm for response-adaptive randomization in stroke clinical trials. Statistical Methods in Medical Research. PMID 25586325 DOI: 10.1177/0962280214567142  0.4
2015 Adeoye O, Sucharew H, Khoury J, Tomsick T, Khatri P, Palesch Y, Schmit PA, Pancioli AM, Broderick JP. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis. Stroke; a Journal of Cerebral Circulation. 46: 461-4. PMID 25523054 DOI: 10.1161/STROKEAHA.114.006743  0.36
2015 Ciolino JD, Martin RH, Zhao W, Hill MD, Jauch EC, Palesch YY. Measuring continuous baseline covariate imbalances in clinical trial data. Statistical Methods in Medical Research. 24: 255-72. PMID 21865270 DOI: 10.1177/0962280211416038  0.36
2015 Zhao W, Hill MD, Palesch Y. Minimal sufficient balance - A new strategy to balance baseline covariates and preserve randomness of treatment allocation Statistical Methods in Medical Research. 24: 989-1002. DOI: 10.1177/0962280212436447  0.36
2014 Wright DW, Yeatts SD, Silbergleit R, Palesch YY, Hertzberg VS, Frankel M, Goldstein FC, Caveney AF, Howlett-Smith H, Bengelink EM, Manley GT, Merck LH, Janis LS, Barsan WG. Very early administration of progesterone for acute traumatic brain injury. The New England Journal of Medicine. 371: 2457-66. PMID 25493974 DOI: 10.1056/NEJMoa1404304  0.36
2014 Palesch YY. Some common misperceptions about P values. Stroke; a Journal of Cerebral Circulation. 45: e244-6. PMID 25378423 DOI: 10.1161/STROKEAHA.114.006138  0.36
2014 Tomsick TA, Yeatts SD, Liebeskind DS, Carrozzella J, Foster L, Goyal M, von Kummer R, Hill MD, Demchuk AM, Jovin T, Yan B, Zaidat OO, Schonewille W, Engelter S, Martin R, ... ... Palesch YY, et al. Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions. Journal of Neurointerventional Surgery. PMID 25342652 DOI: 10.1136/neurintsurg-2014-011318  0.36
2014 Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, von Kummer R, Molina CA, Goyal M, Mazighi M, Schonewille WJ, Engelter ST, et al. Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials. Stroke; a Journal of Cerebral Circulation. 45: 3606-11. PMID 25325911 DOI: 10.1161/STROKEAHA.114.005952  0.36
2014 Elm JJ, Palesch Y, Easton JD, Lindblad A, Barsan W, Silbergleit R, Conwit R, Dillon C, Farrant M, Battenhouse H, Perlmutter A, Johnston SC. Screen failure data in clinical trials: Are screening logs worth it? Clinical Trials (London, England). 11: 467-472. PMID 24925082 DOI: 10.1177/1740774514538706  0.36
2014 Demchuk AM, Goyal M, Yeatts SD, Carrozzella J, Foster LD, Qazi E, Hill MD, Jovin TG, Ribo M, Yan B, Zaidat OO, Frei D, von Kummer R, Cockroft KM, Khatri P, ... ... Palesch YY, et al. Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology. 273: 202-10. PMID 24895878 DOI: 10.1148/radiol.14132649  0.36
2014 Simpson KN, Simpson AN, Mauldin PD, Hill MD, Yeatts SD, Spilker JA, Foster LD, Khatri P, Martin R, Jauch EC, Kleindorfer D, Palesch YY, Broderick JP. Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke; a Journal of Cerebral Circulation. 45: 1791-8. PMID 24876261 DOI: 10.1161/STROKEAHA.113.003874  0.36
2014 Khatri P, Yeatts SD, Mazighi M, Broderick JP, Liebeskind DS, Demchuk AM, Amarenco P, Carrozzella J, Spilker J, Foster LD, Goyal M, Hill MD, Palesch YY, Jauch EC, Haley EC, et al. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. The Lancet. Neurology. 13: 567-74. PMID 24784550 DOI: 10.1016/S1474-4422(14)70066-3  0.36
2014 Yeatts SD, Martin RH, Coffey CS, Lyden PD, Foster LD, Woolson RF, Broderick JP, Di Tullio MR, Jungreis CA, Palesch YY. Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience. Stroke; a Journal of Cerebral Circulation. 45: 1408-14. PMID 24699059 DOI: 10.1161/STROKEAHA.113.003925  0.36
2014 Ciolino JD, Martin RH, Zhao W, Jauch EC, Hill MD, Palesch YY. Continuous covariate imbalance and conditional power for clinical trial interim analyses. Contemporary Clinical Trials. 38: 9-18. PMID 24607294 DOI: 10.1016/j.cct.2014.02.007  0.36
2014 Liebeskind DS, Tomsick TA, Foster LD, Yeatts SD, Carrozzella J, Demchuk AM, Jovin TG, Khatri P, von Kummer R, Sugg RM, Zaidat OO, Hussain SI, Goyal M, Menon BK, Al Ali F, ... ... Palesch YY, et al. Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke; a Journal of Cerebral Circulation. 45: 759-64. PMID 24473178 DOI: 10.1161/STROKEAHA.113.004072  0.36
2014 Hill MD, Demchuk AM, Goyal M, Jovin TG, Foster LD, Tomsick TA, von Kummer R, Yeatts SD, Palesch YY, Broderick JP. Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke; a Journal of Cerebral Circulation. 45: 444-9. PMID 24335227 DOI: 10.1161/STROKEAHA.113.003580  0.36
2014 Desantis SM, Lazaridis C, Palesch Y, Ramakrishnan V. Regression analysis of ordinal stroke clinical trial outcomes: an application to the NINDS t-PA trial. International Journal of Stroke : Official Journal of the International Stroke Society. 9: 226-31. PMID 23803174 DOI: 10.1111/ijs.12052  0.36
2014 Qureshi AI, Majidi S, Gilani WI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, Goldstein JN, Kirmani JF, Hussein HM, Suri MF, Tariq N. Increased brain volume among good grade patients with intracerebral hemorrhage. Results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) study. Neurocritical Care. 20: 470-5. PMID 23609118 DOI: 10.1007/s12028-013-9842-1  0.36
2013 Ciolino JD, Martin RH, Zhao W, Jauch EC, Hill MD, Palesch YY. Covariate imbalance and adjustment for logistic regression analysis of clinical trial data. Journal of Biopharmaceutical Statistics. 23: 1383-402. PMID 24138438 DOI: 10.1080/10543406.2013.834912  0.36
2013 Ginsberg MD, Palesch YY, Hill MD, Martin RH, Moy CS, Barsan WG, Waldman BD, Tamariz D, Ryckborst KJ. High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. The Lancet. Neurology. 12: 1049-58. PMID 24076337 DOI: 10.1016/S1474-4422(13)70223-0  0.36
2013 Yeatts SD, Palesch YY, Moy CS, Selim M. High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods. Neurocritical Care. 19: 257-66. PMID 23943316 DOI: 10.1007/s12028-013-9861-y  0.36
2013 Johnston SC, Easton JD, Farrant M, Barsan W, Battenhouse H, Conwit R, Dillon C, Elm J, Lindblad A, Morgenstern L, Poisson SN, Palesch Y. Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. International Journal of Stroke : Official Journal of the International Stroke Society. 8: 479-83. PMID 23879752 DOI: 10.1111/ijs.12129  0.36
2013 Broderick JP, Tomsick TA, Palesch YY. Endovascular treatment for acute ischemic stroke. The New England Journal of Medicine. 368: 2432-3. PMID 23782182 DOI: 10.1056/NEJMc1304759  0.36
2013 Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, Jauch EC, Jovin TG, Yan B, Silver FL, von Kummer R, Molina CA, Demaerschalk BM, Budzik R, Clark WM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. The New England Journal of Medicine. 368: 893-903. PMID 23390923 DOI: 10.1056/NEJMoa1214300  0.36
2013 Hussein HM, Tariq NA, Palesch YY, Qureshi AI. Reliability of hematoma volume measurement at local sites in a multicenter acute intracerebral hemorrhage clinical trial. Stroke; a Journal of Cerebral Circulation. 44: 237-9. PMID 23233387 DOI: 10.1161/STROKEAHA.112.667220  0.36
2013 Broderick JP, Palesch YY, Demchuk AM. Adding endovascular therapy to t-PA did not improve 90-day survival or functional independence after stroke Annals of Internal Medicine. 158: JC12.  0.36
2012 Sato S, Yamamoto H, Qureshi AI, Palesch YY, Toyoda K. [Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II at Japan site: study design and advance construction of domestic research network]. Rinshō Shinkeigaku = Clinical Neurology. 52: 642-50. PMID 22989898 DOI: DN/JST.JSTAGE/clinicalneurol/52.642  0.36
2012 Elm JJ, Palesch YY, Koch GG, Hinson V, Ravina B, Zhao W. Flexible analytical methods for adding a treatment arm mid-study to an ongoing clinical trial. Journal of Biopharmaceutical Statistics. 22: 758-72. PMID 22651113 DOI: 10.1080/10543406.2010.528103  0.36
2012 Weng Y, Zhao W, Palesch Y. Impact of safety monitoring on error probabilities of binary efficacy outcome analyses in large phase III group sequential trials. Pharmaceutical Statistics. 11: 310-7. PMID 22589042 DOI: 10.1002/pst.1520  0.36
2012 Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz Flores S, Ehtisham A, Goldstein JN, Kirmani JF, Hussein HM, Suri MF, Tariq N. Systolic blood pressure reduction and risk of acute renal injury in patients with intracerebral hemorrhage. The American Journal of Medicine. 125: 718.e1-6. PMID 22560810 DOI: 10.1016/j.amjmed.2011.09.031  0.36
2012 Meurer WJ, Lewis RJ, Tagle D, Fetters MD, Legocki L, Berry S, Connor J, Durkalski V, Elm J, Zhao W, Frederiksen S, Silbergleit R, Palesch Y, Berry DA, Barsan WG. An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project. Annals of Emergency Medicine. 60: 451-7. PMID 22424650 DOI: 10.1016/j.annemergmed.2012.01.020  0.36
2012 Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W. Intramuscular versus intravenous therapy for prehospital status epilepticus. The New England Journal of Medicine. 366: 591-600. PMID 22335736 DOI: 10.1056/NEJMoa1107494  0.36
2012 Seidel SE, Tilley BC, Huang P, Palesch YY, Bergmann KJ, Goetz CG, Swearingen CJ. Subject-investigator reproducibility of the Unified Parkinson's Disease Rating Scale. Parkinsonism & Related Disorders. 18: 230-3. PMID 22018910 DOI: 10.1016/j.parkreldis.2011.10.006  0.36
2012 Hall CE, Mirski M, Palesch YY, Diringer MN, Qureshi AI, Robertson CS, Geocadin R, Wijman CAC, Le Roux PD, Suarez JI. Clinical trial design in the neurocritical care unit Neurocritical Care. 16: 6-19. PMID 21792753 DOI: 10.1007/s12028-011-9608-6  0.36
2012 Zhao W, Weng Y, Wu Q, Palesch Y. Quantitative comparison of randomization designs in sequential clinical trials based on treatment balance and allocation randomness. Pharmaceutical Statistics. 11: 39-48. PMID 21544929 DOI: 10.1002/pst.493  0.36
2012 Brown DL, Johnston KC, Palesch YY. Acute ischemic stroke Clinical Trials in Neurology: Design, Conduct, Analysis. 242-256. DOI: 10.1017/CBO9781139032445.023  0.36
2011 Selim M, Yeatts S, Goldstein JN, Gomes J, Greenberg S, Morgenstern LB, Schlaug G, Torbey M, Waldman B, Xi G, Palesch Y. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke; a Journal of Cerebral Circulation. 42: 3067-74. PMID 21868742 DOI: 10.1161/STROKEAHA.111.617589  0.36
2011 Qureshi AI, Palesch YY. Antihypertensive treatment of acute cerebral hemorrhage (ATACH) II: Design, methods, and rationale Neurocritical Care. 15: 559-576. PMID 21626077 DOI: 10.1007/s12028-011-9538-3  0.36
2011 Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, Ezzeddine MA, Goldstein JN, Kirmani JF, Hussein HM, Suri MF, Tariq N, Liu Y. Association of serum glucose concentrations during acute hospitalization with hematoma expansion, perihematomal edema, and three month outcome among patients with intracerebral hemorrhage. Neurocritical Care. 15: 428-35. PMID 21573860 DOI: 10.1007/s12028-011-9541-8  0.36
2011 Hill MD, Martin RH, Palesch YY, Tamariz D, Waldman BD, Ryckborst KJ, Moy CS, Barsan WG, Ginsberg MD. The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. Stroke; a Journal of Cerebral Circulation. 42: 1621-5. PMID 21546491 DOI: 10.1161/STROKEAHA.110.610980  0.36
2011 Ginsberg MD, Palesch YY, Martin RH, Hill MD, Moy CS, Waldman BD, Yeatts SD, Tamariz D, Ryckborst K. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke; a Journal of Cerebral Circulation. 42: 119-27. PMID 21164127 DOI: 10.1161/STROKEAHA.110.596072  0.36
2011 Ciolino J, Zhao W, Martin R, Palesch Y. Quantifying the cost in power of ignoring continuous covariate imbalances in clinical trial randomization. Contemporary Clinical Trials. 32: 250-9. PMID 21078415 DOI: 10.1016/j.cct.2010.11.005  0.36
2011 Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, Halperin JL, Johnston SC, Katzan I, Kernan WN, Mitchell PH, Ovbiagele B, Palesch YY, Sacco RL, Schwamm LH, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke; a Journal of Cerebral Circulation. 42: 227-76. PMID 20966421 DOI: 10.1161/STR.0b013e3181f7d043  0.36
2011 Tilley BC, Palesch YY. Conduct of Stroke-Related Clinical Trials Stroke. 1192-1203. DOI: 10.1016/B978-1-4160-5478-8.10060-0  0.36
2010 Zhao W, Waldman BD, Dillon C, Pauls K, Kim J, Patterson L, Ginsberg MD, Hill MD, Palesch Y. A web-based medical safety reporting system for a large multicenter clinical trial: the ALIAS experience. Contemporary Clinical Trials. 31: 536-43. PMID 20828636 DOI: 10.1016/j.cct.2010.08.010  0.36
2010 Khatri P, Kleindorfer DO, Yeatts SD, Saver JL, Levine SR, Lyden PD, Moomaw CJ, Palesch YY, Jauch EC, Broderick JP. Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke; a Journal of Cerebral Circulation. 41: 2581-6. PMID 20814000 DOI: 10.1161/STROKEAHA.110.593632  0.36
2010 Zhao W, Ciolino J, Palesch Y. Step-forward randomization in multicenter emergency treatment clinical trials. Academic Emergency Medicine : Official Journal of the Society For Academic Emergency Medicine. 17: 659-65. PMID 20624149 DOI: 10.1111/j.1553-2712.2010.00746.x  0.36
2010 Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, Ezzeddine MA, Goldstein JN, Hussein HM, Suri MF, Tariq N. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Archives of Neurology. 67: 570-6. PMID 20457956 DOI: 10.1001/archneurol.2010.61  0.36
2010 Bath PM, Cotton D, Martin RH, Palesch Y, Yusuf S, Sacco R, Diener HC, Estol C, Roberts R. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Stroke; a Journal of Cerebral Circulation. 41: 732-8. PMID 20181679 DOI: 10.1161/STROKEAHA.109.564906  0.36
2010 Zhao W, Durkalski V, Pauls K, Dillon C, Kim J, Kolk D, Silbergleit R, Stevenson V, Palesch Y. An electronic regulatory document management system for a clinical trial network. Contemporary Clinical Trials. 31: 27-33. PMID 19782156 DOI: 10.1016/j.cct.2009.09.005  0.36
2010 Novitzke J, Martin R, Palesch YY, Qureshi AI. Clinical site activation times for multicenter clinical trials: Lessons learned from the Antihypertensive Treatment of Acute Cerebral Hemorrhage trial Journal of Neuroscience Nursing. 42: E17-E22. DOI: 10.1097/JNN.0b013e3181d5befa  0.36
2009 Bath PM, Martin RH, Palesch Y, Cotton D, Yusuf S, Sacco R, Diener HC, Toni D, Estol C, Roberts R. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke; a Journal of Cerebral Circulation. 40: 3541-6. PMID 19797187 DOI: 10.1161/STROKEAHA.109.555623  0.36
2009 Huang P, Goetz CG, Woolson RF, Tilley B, Kerr D, Palesch Y, Elm J, Ravina B, Bergmann KJ, Kieburtz K. Using global statistical tests in long-term Parkinson's disease clinical trials. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1732-9. PMID 19514076 DOI: 10.1002/mds.22645  0.36
2009 Palesch YY. Design and analysis plans. Frontiers of Neurology and Neuroscience. 25: 76-7. PMID 19478501 DOI: 10.1159/000209479  0.36
2009 Hedden SL, Woolson RF, Carter RE, Palesch Y, Upadhyaya HP, Malcolm RJ. The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials. Journal of Substance Abuse Treatment. 37: 54-63. PMID 19008067 DOI: 10.1016/j.jsat.2008.09.011  0.36
2008 Diener HC, Sacco RL, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, et al. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. The Lancet. Neurology. 7: 875-84. PMID 18757238 DOI: 10.1016/S1474-4422(08)70198-4  0.36
2008 Yusuf S, Diener HC, Sacco RL, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. The New England Journal of Medicine. 359: 1225-37. PMID 18753639 DOI: 10.1056/NEJMoa0804593  0.36
2008 Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BP, Chen ST, Cunha L, Dahlöf B, et al. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. The New England Journal of Medicine. 359: 1238-51. PMID 18753638 DOI: 10.1056/NEJMoa0805002  0.36
2008 Mauldin PD, Simpson KN, Palesch YY, Spilker JS, Hill MD, Khatri P, Broderick JP. Design of the economic evaluation for the Interventional Management of Stroke (III) trial. International Journal of Stroke : Official Journal of the International Stroke Society. 3: 138-44. PMID 18706008 DOI: 10.1111/j.1747-4949.2008.00190.x  0.36
2008 Khatri P, Hill MD, Palesch YY, Spilker J, Jauch EC, Carrozzella JA, Demchuk AM, Martin R, Mauldin P, Dillon C, Ryckborst KJ, Janis S, Tomsick TA, Broderick JP. Methodology of the Interventional Management of Stroke III Trial. International Journal of Stroke : Official Journal of the International Stroke Society. 3: 130-7. PMID 18706007 DOI: 10.1111/j.1747-4949.2008.00151.x  0.36
2008 Tomsick T, Broderick J, Carrozella J, Khatri P, Hill M, Palesch Y, Khoury J. Revascularization results in the interventional management of stroke II trial American Journal of Neuroradiology. 29: 582-587. PMID 18337393 DOI: 10.3174/ajnr.A0843  0.36
2008 Miller SW, Palesch YY. Comments regarding the recent OAST article. Stroke; a Journal of Cerebral Circulation. 39: e14; author reply e1. PMID 18048843 DOI: 10.1161/STROKEAHA.107.500355  0.36
2007 Hill MD, Moy CS, Palesch YY, Martin R, Dillon CR, Waldman BD, Patterson L, Mendez IM, Ryckborst KJ, Tamariz D, Ginsberg MD. The albumin in acute stroke trial (ALIAS); design and methodology. International Journal of Stroke : Official Journal of the International Stroke Society. 2: 214-9. PMID 18705947 DOI: 10.1111/j.1747-4949.2007.00143.x  0.36
2007 Guimaraes P, Palesch Y. Power and sample size simulations for Randomized Play-the-Winner rules Contemporary Clinical Trials. 28: 487-499. PMID 17321219 DOI: 10.1016/j.cct.2007.01.006  0.36
2007 Ginsberg MD, Hill MD, Palesch YY. Response to letter by Muscari and Zoli [7] Stroke. 38: 859. DOI: 10.1161/01.STR.0000257308.07208.1f  0.36
2006 Ginsberg MD, Palesch YY, Hill MD. The ALIAS (ALbumin In Acute Stroke) Phase III randomized multicentre clinical trial: design and progress report. Biochemical Society Transactions. 34: 1323-6. PMID 17073812 DOI: 10.1042/BST0341323  0.36
2006 Hill MD, Demchuk AM, Tomsick TA, Palesch YY, Broderick JP. Using the baseline CT scan to select acute stroke patients for IV-IA therapy American Journal of Neuroradiology. 27: 1612-1616. PMID 16971597  0.36
2006 Ginsberg MD, Hill MD, Palesch YY, Ryckborst KJ, Tamariz D. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results. Stroke; a Journal of Cerebral Circulation. 37: 2100-6. PMID 16809571 DOI: 10.1161/01.STR.0000231388.72646.05  0.36
2006 Palesch YY, Hill MD, Ryckborst KJ, Tamariz D, Ginsberg MD. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis. Stroke; a Journal of Cerebral Circulation. 37: 2107-14. PMID 16809570 DOI: 10.1161/01.STR.0000231389.34701.b5  0.36
2006 Pavlakis SG, Sacco R, Levine SR, Meschia JF, Palesch Y, Tilley BC, Adams HP. Lessons from adult stroke trials. Pediatric Neurology. 34: 446-9. PMID 16765822 DOI: 10.1016/j.pediatrneurol.2005.09.010  0.36
2006 Tilley BC, Palesch YY, Kieburtz K, Ravina B, Huang P, Elm JJ, Shannon K, Wooten GF, Tanner CM, Goetz GC. Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs. Neurology. 66: 628-33. PMID 16534099 DOI: 10.1212/01.wnl.0000201251.33253.fb  0.36
2005 Guimaraes P, Kieburtz K, Goetz CG, Elm JJ, Palesch YY, Huang P, Ravina B, Tanner CM, Tilley BC. Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trials. Clinical Trials (London, England). 2: 509-18. PMID 16422311 DOI: 10.1191/1740774505cn125oa  0.36
2005 Palesch YY, Tilley BC, Sackett DL, Johnston KC, Woolson R. Applying a phase II futility study design to therapeutic stroke trials. Stroke; a Journal of Cerebral Circulation. 36: 2410-4. PMID 16224086 DOI: 10.1161/01.STR.0000185718.26377.07  0.36
2005 Mikhitarian K, Martin RH, Mitas M, Mauldin PD, Palesch Y, Metcalf JS, Cole DJ, Gillanders WE. Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: Results of a multi-institutional prospective cohort study Surgery. 138: 474-481. PMID 16213901 DOI: 10.1016/j.surg.2005.07.001  0.36
2005 Elm JJ, Goetz CG, Ravina B, Shannon K, Wooten GF, Tanner CM, Palesch YY, Huang P, Guimaraes P, Kamp C, Tilley BC, Kieburtz K. A responsive outcome for Parkinson's disease neuroprotection futility studies. Annals of Neurology. 57: 197-203. PMID 15668964 DOI: 10.1002/ana.20361  0.36
2005 Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, ... ... Palesch Y, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 64: 208-15. PMID 15668415 DOI: 10.1212/01.WNL.0000149403.14458.7F  0.36
2004 Palesch YY, Tilley BC. An efficient multi-stage, single-arm Phase II futility design for ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group On Motor Neuron Diseases. 5: 55-6. PMID 15512874 DOI: 10.1080/17434470410020003  0.36
2004 Gillanders WE, Mikhitarian K, Hebert R, Mauldin PD, Palesch Y, Walters C, Urist MM, Mann GB, Doherty G, Herrmann VM, Hill AD, Eremin O, El-Sheemy M, Orr RK, Valle AA, et al. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Annals of Surgery. 239: 828-37; discussion 8. PMID 15166962 DOI: 10.1097/01.sla.0000128687.59439.d6  0.36
2004 Cotton PB, Durkalski VL, Pineau BC, Palesch YY, Mauldin PD, Hoffman B, Vining DJ, Small WC, Affronti J, Rex D, Kopecky KK, Ackerman S, Burdick JS, Brewington C, Turner MA, et al. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. Jama. 291: 1713-9. PMID 15082698 DOI: 10.1001/jama.291.14.1713  0.36
2004 McRae AL, Sonne SC, Brady KT, Durkalski V, Palesch Y. A Randomized, Placebo-controlled trial of Buspirone for the Treatment of Anxiety in Opioid-dependent Individuals American Journal On Addictions. 13: 53-63. PMID 14766438 DOI: 10.1080/10550490490265325  0.36
2004 Cotton PB, Durkalski VL, Pineau BC, Palesch YY, Mauldin PD, Hoffman B, Vining DJ, Small WC, Affronti J, Rex D, Kopecky KK, Ackerman S, Burdick JS, Brewington C, Turner MA, et al. Computed tomographic colonography: What results should we believe? Evidence-Based Gastroenterology. 5: 84-85. DOI: 10.1097/00132579-200408000-00006  0.36
2003 Durkalski VL, Palesch YY, Lipsitz SR, Rust PF. Analysis of clustered matched-pair data. Statistics in Medicine. 22: 2417-28. PMID 12872299 DOI: 10.1002/sim.1438  0.36
2003 Michels PJ, Probst JC, Godenick MT, Palesch Y. Anxiety and anger among family practice residents: a South Carolina family practice research consortium study. Academic Medicine : Journal of the Association of American Medical Colleges. 78: 69-79. PMID 12525412  0.36
2003 Durkalski VL, Palesch YY, Lipsitz SR, Rust PF. Analysis of clustered matched-pair data for a non-inferiority study design. Statistics in Medicine. 22: 279-90. PMID 12520562 DOI: 10.1002/sim.1385  0.36
2002 Durkalski VL, Palesch YY, Pineau BC, Vining DJ, Cotton PB. The virtual colonoscopy study: a large multicenter clinical trial designed to compare two diagnostic screening procedures. Controlled Clinical Trials. 23: 570-83. PMID 12392872 DOI: 10.1016/S0197-2456(02)00232-5  0.36
2001 Wallace MB, Durkalski VL, Vaughan J, Palesch YY, Libby ED, Jowell PS, Nickl NJ, Schutz SM, Leung JW, Cotton PB. Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut. 49: 29-34. PMID 11413107 DOI: 10.1136/gut.49.1.29  0.36
2001 Mitas M, Mikhitarian K, Walters C, Baron PL, Elliott BM, Brothers TE, Robison JG, Metcalf JS, Palesch YY, Zhang Z, Gillanders WE, Cole DJ. Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. International Journal of Cancer. Journal International Du Cancer. 93: 162-71. PMID 11410861 DOI: 10.1002/ijc.1312  0.36
2001 Hebert RL, Palesch YY, Mauldin PD, Tarnasky PR, Aabakken L, Hennessey W, Cotton PB. DDQ-15 health-related quality of life instrument for patients with digestive disorders Health Services and Outcomes Research Methodology. 2: 137-156. DOI: 10.1023/A:1020106129820  0.36
2000 Ables AZ, Blumer NA, Valainis GT, Godenick MT, Kajdasz DK, Palesch YY. Fluconazole prophylaxis of severe candida infection in trauma and postsurgical patients: A prospective, double-blind, randomized, placebo- controlled trial Infectious Diseases in Clinical Practice. 9: 169-175.  0.36
1999 Galbraith GM, Hendley TM, Sanders JJ, Palesch Y, Pandey JP. Polymorphic cytokine genotypes as markers of disease severity in adult periodontitis. Journal of Clinical Periodontology. 26: 705-9. PMID 10589805  0.36
1999 Palesch YY, Valter I, Carpentier PH, Maricq HR. Association between cigarette and alcohol consumption and Raynaud's phenomenon Journal of Clinical Epidemiology. 52: 321-328. PMID 10235172 DOI: 10.1016/S0895-4356(99)00005-0  0.36
1999 Galbraith GM, Palesch Y, Gore EA, Pandey JP. Contribution of interleukin 1beta and KM loci to alopecia areata. Human Heredity. 49: 85-9. PMID 10077728  0.36
1998 Hainer BL, Palesch Y. Symptoms of depression in residents: A South Carolina family practice research consortium study Academic Medicine. 73: 1305-1310. PMID 9883209  0.36
1998 Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction Gastroenterology. 115: 1518-1524. PMID 9834280  0.36
1998 Gore EA, Sanders JJ, Pandey JP, Palesch Y, Galbraith GM. Interleukin-1beta+3953 allele 2: association with disease status in adult periodontitis. Journal of Clinical Periodontology. 25: 781-5. PMID 9797049  0.36
1998 Johnson KE, Sanders JJ, Gellin RG, Palesch YY. The effectiveness of a magnetized water oral irrigator (Hydro Floss®) on plaque, calculus and gingival health Journal of Clinical Periodontology. 25: 316-321. PMID 9565283  0.36
1997 Tarnasky P, Cunningham J, Cotton P, Hoffman B, Palesch Y, Freeman J, Curry N, Hawes R. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis Endoscopy. 29: 252-257. PMID 9255527  0.36
1997 Maricq HR, Carpentier PH, Weinrich MC, Keil JE, Palesch Y, Biro C, Vionnet-Fuasset M, Jiguet M, Valter I. Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison. The Journal of Rheumatology. 24: 879-89. PMID 9150076  0.36
1997 Akazawa K, Nakamura T, Palesch Y. Power of logrank test and Cox regression model in clinical trials with heterogeneous samples Statistics in Medicine. 16: 583-597. PMID 9089965 DOI: 10.1002/(SICI)1097-0258(19970315)16:5<583::AID-SIM433>3.0.CO;2-Z  0.36
1997 Tarnasky PR, Kay C, Cunningham JT, Palesch Y, Pineau B, Cotton PB, Hawes RH. Does it matter where you measure bile duct diameter at ERCP? Gastrointestinal Endoscopy. 45: AB150.  0.36
1997 Tarnasky PR, Palesch Y, Cunningham JT, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction: A prospective randomized trial Gastrointestinal Endoscopy. 45: AB150.  0.36
1996 Maricq HR, Weinrich MC, Valter I, Palesch YY, Maricq JG. Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders Journal of Rheumatology. 23: 2068-2078. PMID 8970043  0.36
1996 Pinosky ML, Fishman RL, Reeves ST, Harvey SC, Patel S, Palesch Y, Dorman BH. The effect of bupivacaine skull block on the hemodynamic response to craniotomy. Anesthesia and Analgesia. 83: 1256-61. PMID 8942596  0.36
1996 Pineau BC, Tarnasky PR, Gordon B, Spicer KM, Gordon L, Palesch Y, Cunningham JT, Cotton PB, Hawes RH. The scintigraphic score: Assessment of interobserver variability and correlation with sphincter of Oddi manometry (SOM) in patients with suspected sphincter of Oddi dysfunction (SOD) Gastrointestinal Endoscopy. 43: 392.  0.36
1995 Godenick MT, Musham C, Palesch Y, Hainer BL, Michels PJ. Physical and psychological health of family practice residents Family Medicine. 27: 646-651. PMID 8582557  0.36
1995 Plankey MW, Stevens J, Palesch Y, Basile JN, Griffin PR. Stability of basal metabolic rate over selected days of the menstrual cycle Obesity Research. 3: 301-302. PMID 7627780  0.36
1994 Walle T, Walle UK, Mathur RS, Palesch YY, Conradi EC. Propranolol metabolism in normal subjects: Association with sex steroid hormones Clinical Pharmacology and Therapeutics. 56: 127-132. PMID 8062488  0.36
Show low-probability matches.